Highly selective small molecular fluorescence probes for detecting α-syn fibrils
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Parkinson's Disease Mechanisms and Treatments · Conducting polymers and applications · Polydiacetylene-based materials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the global burden of disease study 202110.1016/S1474-4422(24)00038-3 ↗
2. Prevalence of Parkinson's disease in adults aged 65 years and older in China: a multicenter population-based survey10.1159/000520726 ↗
3. Disease burden of Parkinson's disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021
4. Diagnosis and treatment of parkinson disease10.1001/jama.2019.22360 ↗
5. Parkinson's disease10.1016/S0140-6736(21)00218-X ↗
6. Parkinson's disease10.1016/S0140-6736(14)61393-3 ↗
7. Mutation in the α-Synuclein gene identified in families with Parkinson's disease10.1126/science.276.5321.2045 ↗
8. Imaging α-synuclein pathologies in animal models and patients with Parkinson’s and related diseases10.1016/j.neuron.2024.05.006 ↗
9. Targeting alpha-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations10.1016/S1474-4422(15)00006-X ↗
10. Characterization of the pathogenic alpha-Synuclein variant V15A in Parkinson s disease10.1038/s41531-023-00584-z ↗
11. Parkinson's disease associated alpha-Synuclein familial mutants promote dopaminergic neuronal death in Drosophila melanogaster10.1021/acschemneuro.8b00107 ↗
12. E46K alpha-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation10.1073/pnas.1703420114 ↗
13. Parkinson's disease associated mutation E46K of alpha-synuclein triggers the formation of a distinct fibril structure10.1038/s41467-020-16386-3 ↗
14. Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease10.1039/D0CS00115E ↗
15. Development and challenge of fluorescent probes for bioimaging applications: from visualization to diagnosis10.1007/s41061-022-00376-8 ↗
16. Detection of oligomers and fibrils of alpha-synuclein by AIEgen with strong fluorescence10.1039/C4CC07911F ↗
17. Novel benzothiazole derivatives as fluorescent probes for detection of beta-amyloid and alpha-Synuclein aggregates10.1021/acschemneuro.6b00450 ↗
18. Binding of the radioligand SIL23 to alpha-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent10.1371/journal.pone.0055031 ↗
19. Design, synthesis, and characterization of 3-(Benzylidene)indolin-2-one derivatives as ligands for alpha-Synuclein fibrils10.1021/acs.jmedchem.5b00571 ↗
20. Smart near-infrared fluorescence probes with donor-acceptor structure for in vivo detection of beta-amyloid deposits10.1021/ja4052922 ↗
21. Novel stilbenes as probes for amyloid plaques10.1021/ja0167147 ↗
22. The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease10.1186/s40478-017-0456-2 ↗
23. Specific fluorescent detection of fibrillar alpha-synuclein using mono- and trimethine cyanine dyes10.1016/j.bmc.2007.10.051 ↗
24. Near-infrared fluorescent probes as imaging and Theranostic modalities for amyloid-beta and tau aggregates in alzheimer's disease10.1021/acs.jmedchem.1c01619 ↗
25. Keto form of curcumin derivatives strongly binds to Abeta oligomers but not fibrils10.1016/j.biomaterials.2021.120686 ↗
26. Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits10.1021/ja9047043 ↗
27. Non-conjugated small molecule FRET for differentiating monomers from higher molecular weight amyloid beta species10.1371/journal.pone.0019362 ↗
28. Curcumin analogues as selective fluorescence imaging probes for brown adipose tissue and monitoring browning
29. Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease10.1021/ja405239v ↗
30. Computational screening of nanoparticles coupling to Abeta40 peptides and fibrils10.1038/s41598-019-52594-8 ↗
31. Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils10.1073/pnas.0806270105 ↗
32. Development of an alpha-synuclein positron emission tomography tracer for imaging synucleinopathies10.1016/j.cell.2023.06.004 ↗
33. Binding adaptability of chemical ligands to polymorphic alpha-synuclein amyloid fibrils10.1073/pnas.2321633121 ↗